13 September 2016, London

Post-Brexit and with escalating costs of patents and no Unified Patents Court, we ask might copyright protection offer a more cost-effective protection to recombinant derived small molecule pharmaceuticals?

Mark Engelman, Michael Kock and Martin Gouldstone will cover the following topics:

  • IP Protection for DNA Sequences: Patents vs. Copyright – Challenges, Limitations, Opportunities
  • Legal developments in copyright and gene sequences
  • The science of gene sequences